Delivery Order SPE2DB22D2206-SPE2DB23FJD01
Award Date 7/12/23
Potential Completion Date 7/13/23
Potential Value $1.9K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,923.48 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 50 mg vials of the antifungal medication Ambisome. The order is to be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania facility by July 13, 2023 in support of the Defense Logistics Agency's medical supply procurement programs. No set aside designation or subcontractors were indicated. The brief period of performance suggests this delivery order was placed to...
- The Defense Logistics Agency awarded a $1,923.48 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 50 mg vials of the antifungal medication Ambisome. The prime contractor, Amerisourcebergen Drug Corporation, will deliver the products from its Conshohocken, Pennsylvania location to fulfill requirements under the delivery order. The Defense Logistics Agency routinely issues delivery orders against its Prime Vendor contracts to supply medical products to various Department...
- The Defense Logistics Agency issued a $2,542.90 delivery order to Amerisourcebergen Drug Corp on May 15, 2026, for Ambisome 50 mg vials, with an ultimate completion date of May 18, 2026. Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside applied. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., and serves as the execution entity for DLA pharmaceutical distribution under the DLA Troop Support Medical indefinite delivery contract structure...
- The Defense Logistics Agency awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4563184708 AMBISOME 50 MG VIALS. The contract has a potential value of $1,923.48 and a completion date of December 28, 2023. Amerisourcebergen Drug Corp, through its Corporate Office division, is a prime contractor that provides pharmaceutical products and services to U.S. government agencies, primarily the Department of...
- <p>The Defense Logistics Agency issued a $4,661.14 delivery order to Amerisourcebergen Drug Corp on May 26, 2026, for Ambisome 50 mg vials, with ultimate completion on May 27, 2026.</p> <p>Place of performance is Conshohocken, PA. The order is priced firm fixed-price with no set-aside. The source does not identify the parent indefinite delivery contract vehicle by name or provide a period of performance beyond the completion date.</p>
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 1, 2025, for the supply of AmBisome 50 mg vials, a specialized antifungal pharmaceutical product. This competitively awarded, non-set-aside contract carries a ceiling value of $7,741.00 with firm fixed pricing and an ultimate completion date of September 2, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a $2,598.40 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 50 milligrams of Amphotericin B liposome. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical product from its facility in Conshohocken, Pennsylvania to fulfill DLA's requirements by July 27, 2023. Amerisourcebergen Corporation is the identified parent company for Amerisourcebergen Drug Corporation. No subcontractors or set...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of AmBisome 50 mg vials, a critical antifungal medication used in military and federal healthcare settings. This non-set-aside, competitively awarded delivery order carries a ceiling value of $1,291.80 under firm fixed price terms, with a completion date of September 22, 2025. The contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery...
- This federal contract award is for the delivery of AMBISOME 50 MG VIALS to the Defense Logistics Agency (DLA). The $1,923.48 firm fixed price delivery order was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., which serves as the primary vehicle for the company to supply a comprehensive range...
- This federal contract award is for the delivery of AmBisome 50 mg vials, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,923.48 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., holds with the DLA Troop...